Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001907137 | SCV002126927 | uncertain significance | Vici syndrome | 2022-01-27 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. This variant has not been reported in the literature in individuals affected with EPG5-related conditions. This variant is present in population databases (rs777041802, gnomAD 0.02%). This sequence change affects codon 966 of the EPG5 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the EPG5 protein. |